Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: one-year kidney allograft outcomes | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: one-year kidney allograft outcomes

Molnar MZ, Azhar A, Tsujita M, et al. Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: one-year kidney allograft outcomes. Am J Kidney Dis [Internet]. 2021;77(5):739-747. https://doi.org/10.1053/j.ajkd.2020.10.017

Publication Type:

Journal Article

Authors:

Molnar, MZ; Azhar, A; Tsujita, M; et, al

Source:

Am J Kidney Dis, Volume 77, Issue 5, p.739-747 (2021)

URL:

https://doi.org/10.1053/j.ajkd.2020.10.017

Keywords:

calculated panel reactive antibodies (cPRA), cytomegalovirus (CMV), direct antiviral agent (DAA), donation after circulatory death (DCD), donor-specific antibodies (DSA), estimated glomerular filtration rate (eGFR), kidney donor profile index (KDPI), nucleic acid test (NAT), polymerase chain reaction (PCR), sustained virologic response (SVR)

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/33333148/

Export Citation:

RIS Format

Top